PorA types in Neisseria meningitidis serogroup B isolated in Argentina from 2001 to 2003: Implications for the design of an outer membrane protein-based vaccine

Journal of Medical Microbiology

Volumn 57, Issue 3, 2008, Pages 338-342

  Pereira, Cecilia Sorhouet ^a,b   Regueira, Mabel ^b   Mollerach, Marta ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b INSTITUTO NACIONAL DE ENFERMEDADES INFECCIOSAS   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

PORIN A;

ARGENTINA; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; IMMUNOGLOBULIN VARIABLE REGION; MICROBIAL DIVERSITY; NEISSERIA MENINGITIDIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN STRUCTURE; SEROTYPE;

ARGENTINA; BASE SEQUENCE; DRUG DESIGN; GENOTYPE; HUMANS; MENINGOCOCCAL INFECTIONS; MENINGOCOCCAL VACCINES; MOLECULAR SEQUENCE DATA; NEISSERIA MENINGITIDIS, SEROGROUP B; POPULATION SURVEILLANCE; PORINS; PROMOTER REGIONS (GENETICS); SEQUENCE ANALYSIS, DNA; SEROTYPING; VARIATION (GENETICS);

EID: 40549087244     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.47631-0     Document Type: Article

References (29)

1. Abdillahi, H. & Poolman, J. T. (1987). Whole-cell ELISA for typing Neisseria meningitidis with monoclonal antibodies. FEMS Microbiol Lett 48, 367-371.
2. Bilukha, O. O. & Rosenstein, N. (2005). Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 54 (RR-7), 1-21.
3. Cartwright, K., Morris, R., Rumke, H., Fox, A., Borrow, R., Begg, N., Richmond, P. & Pollman, J. (1999). Immunogenicity in UK infants of a novel meningococcal vesicle vaccine containing multiple class 1 (PorA) outer membrane proteins. Vaccine 17, 2612-2619.
4. Chiavetta, L., Chávez, E., Ruzic, A., Mollerach, M. & Regueira, M. (2007). Surveillance of Neisseria meningitidis in Argentina, 1993-2005: distribution of serogroups, serotypes and serosubtypes isolated from invasive disease. Rev Argent Microbiol 39, 21-27 (in Spanish).
5. Clarke, S. C., Diggle, M. A., Mölling, P., Unemo, M. & Olcén, P. (2003). Analysis of PorA variable region 3 in meningococci: implications for vaccine policy? Vaccine 21, 2468-2473.
6. Derrick, J. P., Urwin, R., Suker, J., Feavers, I. M. & Maiden, M. C. (1999). Structural and evolutionary inference from molecular variation in Neisseria porins. Infect Immun 67, 2406-2413.
7. Feavers, I. M. & Maiden, M. C. (1998). A gonococcal porA pseudogene: implications for understanding the evolution and pathogenicity of Neisseria gonorrhoeae. Mol Microbiol 30, 647-656.
8. Finne, J., Leinonen, M. & Mäkelä, P. H. (1983). Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis. Lancet 2, 355-357.
9. Frasch, C. E., Zollinger, W. D. & Poolman, J. T. (1985). Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes. Rev Infect Dis 7, 504-510.
10. Harrison, L. H. (2006). Prospects for vaccine prevention of meningococcal infection. Clin Microbiol Rev 19, 142-164.
11. Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
12. Lemos, A. P. S., Brandao, A. P., Gorla, M. C. O., Paiva, M. V., Simonsen, V. & Melles, C. E. A. (2006). Phenotypic characterization of Neisseria meningitidis strains isolated from invasive disease in Brazil from 1990 to 2001. J Med Microbiol 55, 751-757.
13. Maiden, M. C., Suker, J., McKenna, A. J., Bygraves, J. A. & Feavers, I. M. (1991). Comparison of the class 1 outer membrane proteins of eight serological reference strains of Neisseria meningitidis. Mol Microbiol 5, 727-736.
14. Mocca, L. F. & Frasch, C. E. (1982). Sodium dodecyl sulfate-polyacrylamide gel typing system for characterization of Neisseria meningitidis isolates. J Clin Microbiol 16, 240-244.
15. O'Hallahan, J., Lennon, D. & Oster, P. (2004). The strategy to control New Zealand's epidemic of group B meningococcal disease. Pediatr Infect Dis J 23, S293-S298.
16. Peeters, C. C., Rümke, H. C., Sundermann, L. C., Rouppe van der Voort, E. M., Meulenbelt, J., Schuller, M., Kuipers, A. J., van der Ley, P. & Poolman, J. T. (1996). Phase I clinical trial with a hexavalent PorA containing meningococcal outer membrane vesicle vaccine. Vaccine 14, 1009-1015.
17. Pollard, A. J. & Moxon, E. R. (2002). The meningococcus tamed? Arch Dis Child 87, 13-17.
18. Rosenqvist, E., Hoiby, E. A., Wedege, E., Bryn, K., Kolberg, J., Klem, A., Ronnild, E., Bjune, G. & Nokleby, H. (1995). Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine. Infect Immun 63, 4642-4652.
19. Russell, J. E., Jolley, K. A., Feavers, I. M., Maiden, M. C. & Sukert, J. (2004). PorA variable regions of Neisseria meningitidis. Emerg Infect Dis 10, 674-678.
20. Sacchi, C. T., Lemos, A. P., Brandt, M. E., Withey, A. M., Melles, C. E. A., Solari, C. A., Frasch, C. E. & Mayer, L. W. (1998). Proposed standardization of Neisseria meningitidis PorA variable-region typing nomenclature. Clin Diagn Lab Immunol 5, 845-855.
21. Sacchi, C. T., Withey, A. M., Popovic, T., Beall, D. S., Reeves, M. W., Plikaytis, B. D., Rosenstein, N. E., Perkins, B. A., Tondella, M. L. & Mayer, L. W. (2000). Diversity and prevalence of PorA types in Neisseria meningitidis serogroup B in the United States, 1992-1998. J Infect Dis 182, 1169-1176.
22. Sacchi, C. T., Lemos, A. P., Popovic, T., de Morais, J. C., Whitney, A. M., Melles, C. E. A., Brondi, L. M. G., Monteiro, L. M. C., Paiva, M. V. & other authors (2001). Serosubtypes and PorA types of Neisseria meningitidis serogroup B isolated in Brazil during 1997-1998. Overview and implications for vaccine development. J Clin Microbiol 39, 2897-2903.
23. Sánchez, S., Abel, A., Arenas, J., Criado, M. T. & Ferreirós, C. M. (2005). Cross-linking analysis of antigenic outer membrane protein complex of Neisseria meningitidis. Res Microbiol 157, 136-142.
24. Taha, M. K. & Alonso, J. M. (2007). Meningococcal vaccines: to eradicate the disease, not the bacterium. Hum Vaccin 3, 149-152.
25. van der Ende, A., Hopman, C. T., Zaat, S., Essink, B. B., Berkhout, B. & Dankert, J. (1995). Variable expression of class 1 outer membrane protein in Neisseria meningitidis is caused by variation in the spacing between -10 and -35 regions of the promoter. J Bacteriol 177, 2475-2480.
26. van der Ende, A., Hopman, C. T. P. & Dankert, J. (1999). Deletion of porA by recombination between clusters of repetitive extragenic palindromic sequences in Neisseria meningitidis. Infect Immun 67, 2928-2934.
27. van der Ley, P., Heckles, J. E., Virji, M., Hoogerhout, P. & Poolman, J. T. (1991). Topology of outer membrane porins in pathogenic Neisseria spp. Infect Immun 59, 2963-2971.
28. van der Ley, P., van der Biezen, J., Hohenstein, P., Peeters, C. & Poolman, J. T. (1993). Use of transformation to construct antigenic hybrids of the class 1 outer membrane protein in Neisseria meningitidis. Infect Immun 61, 4217-4224.
29. Vicente, D., Esnal, O., Michaus, L., López de Goicoechea, M. J., Cisterna, R. & Pérez-Trallero, E. (2005). Prevalence of genosubtypes (PorA types) of serogroup B invasive meningococcus in the north of Spain from 2000 to 2003. J Med Microbiol 54, 381-384.